DIVIDEND ANNOUNCEMENT: Becton, Dickinson & Co (NYSE:BDX) on 01/24/2023 declared a dividend of $0.9100 per share

Becton, Dickinson & Co (NYSE:BDX) on 01/24/2023 declared a dividend of $ 0.9100 per share payable on March 31, 2023 to shareholders of record as of March 10, 2023.

Becton, Dickinson & Co (NYSE:BDX) has paid dividends since 1926, has a current dividend yield of 1.4584501982% and has increased its dividends for 11 successive years.

Becton, Dickinson & Co's market cap is $ 70,724,982,080 and has a PE ratio of 42.45. The stock price closed yesterday at $ 249.58 and has a 52 week low/high of $ 215.90 and $ 277.29.

Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s operations consist of three business segments: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems; and BD Interventional, which provides vascular, urology, oncology and surgical products.

For more information on Becton, Dickinson & Co click here.